Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,841,018
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
455,904
-
Shares change
-
+40,267
-
Total reported value, excl. options
-
$1,335,000
-
Value change
-
+$144,563
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$2.93
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q2 2020
15 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 455,904 shares
of 105,841,018 outstanding shares and own 0.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (159,108 shares), BlackRock Inc. (100,422 shares), GEODE CAPITAL MANAGEMENT, LLC (60,614 shares), Virtu Financial LLC (33,296 shares), Squarepoint Ops LLC (32,406 shares), Bank of New York Mellon Corp (16,109 shares), RENAISSANCE TECHNOLOGIES LLC (14,360 shares), WINTON GROUP Ltd (12,105 shares), DIMENSIONAL FUND ADVISORS LP (11,909 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (10,778 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.